Kaoru Hatano

940 total citations
37 papers, 389 citations indexed

About

Kaoru Hatano is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Kaoru Hatano has authored 37 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Kaoru Hatano's work include Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Kaoru Hatano is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Lymphoblastic Leukemia research (6 papers). Kaoru Hatano collaborates with scholars based in Japan and United States. Kaoru Hatano's co-authors include Iekuni Oh, Kazuo Muroi, Kazuya Sato, Shin‐ichiro Fujiwara, Tadashi Nagai, Masaki Mori, Ken Ohmine, Yusuke Furukawa, Jiro Kikuchi and Yoshinobu Kanda and has published in prestigious journals such as Blood, PLoS ONE and Oncogene.

In The Last Decade

Kaoru Hatano

33 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaoru Hatano Japan 10 263 141 107 68 61 37 389
Jacopo Olivieri Italy 11 134 0.5× 75 0.5× 74 0.7× 56 0.8× 81 1.3× 24 374
Brittany A. Woods United States 5 198 0.8× 155 1.1× 47 0.4× 77 1.1× 180 3.0× 8 385
Erminia Rinaldi Italy 5 139 0.5× 98 0.7× 194 1.8× 59 0.9× 77 1.3× 9 338
Ali Amin Asnafi Iran 10 209 0.8× 69 0.5× 29 0.3× 75 1.1× 73 1.2× 35 350
A Jacobs United Kingdom 7 240 0.9× 158 1.1× 120 1.1× 92 1.4× 97 1.6× 12 421
Yoshikazu Sudo Japan 10 224 0.9× 64 0.5× 103 1.0× 131 1.9× 85 1.4× 14 369
Jun Kuyama Japan 9 198 0.8× 93 0.7× 36 0.3× 101 1.5× 40 0.7× 17 327
Curtis Je Canada 9 220 0.8× 167 1.2× 88 0.8× 78 1.1× 56 0.9× 12 388
José María Fernández‐Rañada Spain 10 136 0.5× 101 0.7× 127 1.2× 122 1.8× 134 2.2× 16 349
Gerlinde Mitterbauer‐Hohendanner Austria 10 327 1.2× 88 0.6× 99 0.9× 107 1.6× 215 3.5× 20 530

Countries citing papers authored by Kaoru Hatano

Since Specialization
Citations

This map shows the geographic impact of Kaoru Hatano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaoru Hatano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaoru Hatano more than expected).

Fields of papers citing papers by Kaoru Hatano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaoru Hatano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaoru Hatano. The network helps show where Kaoru Hatano may publish in the future.

Co-authorship network of co-authors of Kaoru Hatano

This figure shows the co-authorship network connecting the top 25 collaborators of Kaoru Hatano. A scholar is included among the top collaborators of Kaoru Hatano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaoru Hatano. Kaoru Hatano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toda, Yumiko, Masahiro Ashizawa, Takashi Ikeda, et al.. (2024). Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era. International Journal of Hematology. 119(6). 660–666.
3.
Fujiwara, Shin‐ichiro, Takashi Ikeda, Yumiko Toda, et al.. (2022). Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation. Leukemia Research. 121. 106951–106951. 5 indexed citations
4.
Hatano, Kaoru, Shin‐ichiro Fujiwara, Kento Umino, et al.. (2022). Clinical interaction between dexamethasone and aprepitant in chemotherapy for lymphoma. Annals of Hematology. 101(6). 1211–1216. 3 indexed citations
5.
Mashima, Kiyomi, Iekuni Oh, Ken Fujiwara, et al.. (2021). Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models. PLoS ONE. 16(1). e0245232–e0245232. 6 indexed citations
6.
Morita, Kaoru, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2020). Identification of endoscopic factors that predict poor responses to steroids in patients with gastrointestinal acute graft-versus-host disease. Bone Marrow Transplantation. 56(4). 963–967. 1 indexed citations
7.
Ito, Shoko, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2019). Evaluation of thrombotic events in patients with immune thrombocytopenia. Annals of Hematology. 99(1). 49–55. 14 indexed citations
8.
Umino, Kento, Shin‐ichiro Fujiwara, Takashi Ikeda, et al.. (2018). Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement. Hematology. 23(8). 470–477. 20 indexed citations
9.
Kawasaki, Yasufumi, Kazuya Sato, Hiroko Hayakawa, et al.. (2018). Comprehensive Analysis of the Activation and Proliferation Kinetics and Effector Functions of Human Lymphocytes, and Antigen Presentation Capacity of Antigen-Presenting Cells in Xenogeneic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 24(8). 1563–1574. 24 indexed citations
10.
Mashima, Kiyomi, Iekuni Oh, Takashi Ikeda, et al.. (2018). Role of Sequential Monitoring of WT1 Gene Expression in Patients With Acute Myeloid Leukemia for the Early Detection of Leukemia Relapse. Clinical Lymphoma Myeloma & Leukemia. 18(12). e521–e527. 12 indexed citations
11.
Ito, Shoko, Shin‐ichiro Fujiwara, Kiyomi Mashima, et al.. (2017). Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia. Annals of Hematology. 96(5). 719–724. 9 indexed citations
12.
Umino, Kento, Shin‐ichiro Fujiwara, Kazuya Sato, et al.. (2017). High-Dose Methotrexate and Cytarabine-Based Multi-Agent Chemotherapy (Modified Bonn Protocol) for Systemic Lymphoma with CNS Involvement. Acta Haematologica. 137(2). 93–99. 3 indexed citations
13.
Fujiwara, Shin‐ichiro, Takashi Ikeda, Yumiko Toda, et al.. (2017). Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia. International Journal of Hematology. 106(3). 411–417. 1 indexed citations
16.
Suzuki, Takahiro, Hiroyuki Kobayashi, Yasufumi Kawasaki, et al.. (2016). Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations. International Journal of Hematology. 104(4). 446–453. 16 indexed citations
17.
Hatano, Kaoru, Tadashi Nagai, Tomohiro Matsuyama, et al.. (2014). Leukemia Cells Directly Phagocytose Blood Cells in AML-Associated Hemophagocytic Lymphohistiocytosis: A Case Report and Review of the Literature. Acta Haematologica. 133(1). 98–100. 4 indexed citations
18.
Muroi, Kazuo, Shin‐ichiro Fujiwara, Raine Tatara, et al.. (2013). CD56 Expression in Normal Immature Granulocytes after Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Clinical and Experimental Hematopathology. 53(3). 247–250. 6 indexed citations
19.
Nagai, Tadashi, et al.. (2013). Romidepsin Overcomes Cell Adhesion-Mediated Drug Resistance in Multiple Myeloma Cells. Acta Haematologica. 132(1). 1–4. 7 indexed citations
20.
Hatano, Kaoru, Jiro Kikuchi, Masaaki Takatoku, et al.. (2008). Bortezomib Overcomes Cell Adhesion-Mediated Drug Resistance Via Down-Regulation of VLA-4 Expression in Multiple Myeloma.. Blood. 112(11). 1634–1634. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026